The systemic antiangiogenic effect of intravitreal aflibercept injection in a mouse model of retinopathy of prematurity
- 10 February 2021
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 35 (3), e21390
- https://doi.org/10.1096/fj.202002414r
Abstract
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness and intravitreal anti-vascular endothelial growth factor (VEGF) injection is becoming a first-line choice for treatment of ROP. However, there is a major concern that intravitreally injected anti-VEGF agents could escape from the eye into the systemic circulation and impair systemic development. Moreover, escaped anti-VEGF agents could have an effect on the retina of the fellow eye. In this study, we investigated the hematogenous effect of a single intravitreal anti-VEGF injection in a mouse model of ROP. Here, we showed that single intravitreal aflibercept injection to one eye can affect body weight gain, the fellow eye, and renal vessels, although no apparent effect was observed in brain vessels. Furthermore, this hematogenous effect was dose-dependent. Our results provide very important insights into the clinical use of anti-VEGF agents for ROP treatment.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (19K18877)
This publication has 38 references indexed in Scilit:
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of PrematurityThe New England Journal of Medicine, 2011
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast CancerJournal of Clinical Oncology, 2010
- VEGF Inhibition and Renal Thrombotic MicroangiopathyThe New England Journal of Medicine, 2008
- Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for controlEarly Human Development, 2008
- Renal Function in Early Childhood in Very Low Birthweight InfantsAmerican Journal of Perinatology, 2007
- VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal NeovascularizationThe Journal of Experimental Medicine, 2003
- VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodiaThe Journal of cell biology, 2003
- Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.JCI Insight, 1997
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996